Literature DB >> 19461657

Analysis of a t(18;21)(p11.1;p11.1) translocation in a family with schizophrenia.

Joanne M A Meerabux1, Hisako Ohba, Yoshimi Iwayama, Motoko Maekawa, Sevilla D Detera-Wadleigh, Lynn E DeLisi, Takeo Yoshikawa.   

Abstract

It is suggested that chromosome 18p11 is a susceptibility region for both bipolar disorder and schizophrenia. Aiming to identify susceptibility gene(s), we investigated a family whose members have either schizophrenia or schizophrenia-spectrum psychosis and carried a t(18;21)(p11.1;p11.1) translocation. Fluorescence in situ hybridization showed that the breakpoint on chromosome 21 was localized to a bacterial artificial chromosome (BAC) clone RP11-2503J9, which contained coding sequences for transmembrane phosphatase with tensin homology, although this gene was not disrupted. On chromosome 18p, the break point was narrowed to BAC clone RP11-527H14. In silico sequence analysis of this clone identified possible pseudo genes and gene fragments but no intact genes. RP11-527H14 also showed sites of cross hybridization, including 21p11.1. To test for a position effect on 18p11 sequences translocated to 21p11, we performed quantitative RT-PCR to measure the expression of the candidate gene C18orf1 in translocation carriers, but found no significant differences from controls in lymphoblastoid cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461657     DOI: 10.1038/jhg.2009.47

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

1.  Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.

Authors:  Michael E Talkowski; Jill A Rosenfeld; Ian Blumenthal; Vamsee Pillalamarri; Colby Chiang; Adrian Heilbut; Carl Ernst; Carrie Hanscom; Elizabeth Rossin; Amelia M Lindgren; Shahrin Pereira; Douglas Ruderfer; Andrew Kirby; Stephan Ripke; David J Harris; Ji-Hyun Lee; Kyungsoo Ha; Hyung-Goo Kim; Benjamin D Solomon; Andrea L Gropman; Diane Lucente; Katherine Sims; Toshiro K Ohsumi; Mark L Borowsky; Stephanie Loranger; Bradley Quade; Kasper Lage; Judith Miles; Bai-Lin Wu; Yiping Shen; Benjamin Neale; Lisa G Shaffer; Mark J Daly; Cynthia C Morton; James F Gusella
Journal:  Cell       Date:  2012-04-19       Impact factor: 41.582

2.  C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.

Authors:  Naoko Nakano; Kota Maeyama; Nobuo Sakata; Fumiko Itoh; Ryosuke Akatsu; Miki Nakata; Yuki Katsu; Souichi Ikeno; Yoko Togawa; Thanh Thao Vo Nguyen; Yukihide Watanabe; Mitsuyasu Kato; Susumu Itoh
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

3.  Two novel genomic regions associated with fearfulness in dogs overlap human neuropsychiatric loci.

Authors:  R Sarviaho; O Hakosalo; K Tiira; S Sulkama; E Salmela; M K Hytönen; M J Sillanpää; H Lohi
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

4.  Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate.

Authors:  Benjamin Georgi; David Craig; Rachel L Kember; Wencheng Liu; Ingrid Lindquist; Sara Nasser; Christopher Brown; Janice A Egeland; Steven M Paul; Maja Bućan
Journal:  PLoS Genet       Date:  2014-03-13       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.